Search Results
23 Results Found for “leadless”
At EHRA 2026, Professor Claudio Tondo presents his highlights on advances in ablation and device technologies, led by pulsed field ablation, showcasing a rapidly evolving landscape in the treatment of complex arrhythmias.
At EHRA 2026, late-breaking trials across ablation, devices, and drug therapy signal major shifts in arrhythmia management, highlighting both rapid innovation and key unanswered questions. We spoke to Prof Jose Luis Merino for his highlights.
From EHRA 2026, Dr Salik Ur Rehman discusses advances in pulsed field ablation, mapping technologies, and conduction system pacing highlight a rapidly evolving landscape in electrophysiology care.
As 2025 draws to a close, we’re celebrating another remarkable year of growth, collaboration and innovation at touchCARDIO. From thought-provoking expert interviews and peer-reviewed research to dynamic conference coverage and an expanding portfolio of medical education, this year has been defined by meaningful conversations and impactful learning. We’ve had the privilege of engaging with leading clinicians, researchers and partner societies across the globe - bringing together diverse voices to support the cardiology community with timely, accessible and authoritative content. As we reflect on the past 12 months, we’re proud to highlight the moments, milestones and stories that shaped our year.
Welcome to this issue of Heart International. As ever, we aim to provide our readers with the latest developments, insights, and evidence-based discussions in cardiovascular care. This edition is particularly poignant, as we begin with a heartfelt tribute to an ...
The first-in-human implantation of a leadless pacing system occurred already more than 10 years ago.1 The first-generation ventricular leadless pacemaker could provide only asynchronous ventricular pacing (ventricular, ventricular, inhibited [VVI], or ventricular, ventricular, inhibited, rate response [VVIR]), limiting its indications to ...
The OptiVALL study aimed to assess the atrioventricular synchronous pacing capabilities of the Micra AV device, and to describe what programming changes are needed. In this touchCARDIO interview, we speak with Dr Sem Briongos Figuero (Hospital Infanta Leonor, Madrid, Spain) ...
The MARVEL 2 trial studied atrioventricular synchronous pacing in patients with a Micra leadless ventricular pacemaker. In this touchCARDIO interview, we speak with Dr Sem Briongos Figuero (Hospital Infanta Leonor, Madrid, Spain) to discuss the trials studying atrioventricular synchrony and their ...
Prof. Haran Burri (Lead Cardiac Physiologist, University of Oxford, Oxford, UK) gave us an update on the future of pacing from the European Heart Rhythm Association (EHRA) Virtual Meeting 2021. Questions: What is the potential role of conduction system pacing as ...
Introduction: Leadless left ventricular (LV) endocardial pacing with the WiSE-CRT System (EBR Systems Inc) is a novel treatment in the field of cardiac resynchronization therapy (CRT). The system was designed to provide lateral wall LV pacing (LVP) in response to ...
Introduction: Transcatheter leadless pacemakers are increasingly being used for the treatment of bradyarrhythmia. Data following conventional transvenous pacemaker implantation suggests same-day discharges are safe and have become the standard of care in many institutions around the world. There is limited ...
Background: Radiation therapy (RT) is a standard modality for cancer treatment for patients with cardiac implantable electronic devices (CIEDs). The increased ageing population has influenced the number of patients receiving radiation therapy, and concurrently the number of patients undergoing implantation ...
Case: A 58-year-old male with dual chamber pacemaker implanted 14 years previously for sinus node disease presented with red papular rash and burning pain over pacemaker site. He was initially treated with antibiotics for presumed device relate infection. Normal white cell ...
Implantation of cardiac implantable electronic devices (CIEDs) remains one of the core skills of cardiologists; most cardiology trainees will require at least basic skills in permanent pacemaker (PPM) implantation.1 The aim of this article is to provide a guide ...
Case report A 50-year-old man with a history of myocardial infarction (MI) in 2006 and arterial hypertension presented with episodes of paroxysmal atrio-ventricular block (AVB). He was also affected by severe obesity (353 kg) with a body mass index (BMI) of 121 kg/...
Welcome to the winter edition of the European Journal of Arrhythmia and Electrophysiology. Throughout 2016, we have featured a number of topical reviews, research articles, case reports and editorials across the field of arrhythmia and electrophysiology. Insertion of implantable cardiac devices ...
The subcutaneous implantable cardioverter-defibrillator (S-ICD) is a disruptive technological change in our approach to ICD implantation avoiding the Achilles’ heel of the transvenous lead impantation in patients without pacing indications. The evidence base has been significantly expanded over the past 12 ...
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
